Skip to content

46 Xy Differences Of Sex Development C2751824

Published: July 22, 2026Updated: August 27, 2026

A condition where genetic, anatomical, or hormonal factors lead to variations in typical male sex development. Care involves a multidisciplinary team addressing medical, emotional, and social needs.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
Q55.9
ICD-11
LA00.0
Body system
reproductive
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Salt-wasting crisis

Life-threatening electrolyte imbalance with severe dehydration and low blood pressure, seen in some forms of 46-XY DSD.

EMERGENCY: Seek immediate medical care if experiencing severe vomiting, weakness, or fainting.

Ambiguous genitalia

(reproductive)

External genitalia that do not clearly appear male or female at birth due to atypical development.

Frequency: 70-80% of patients

Micropenis

(reproductive)

Abnormally small penis size at birth, typically less than 2.5 cm in length.

Frequency: 50-60% of patients

Cryptorchidism

(reproductive)

One or both testicles fail to descend into the scrotum before birth.

Frequency: 30-50% of patients

Hypospadias

(reproductive)

Urethral opening develops on the underside of the penis instead of the tip.

Frequency: 20-30% of patients

Primary amenorrhea

(reproductive)

Absence of menstrual periods by age 15 or after 3 years of no menstruation in individuals with female phenotype.

Frequency: Up to 90% of patients with female phenotype

Gonadal dysgenesis

(reproductive)

Underdeveloped or abnormal gonadal tissue that may not produce adequate hormones.

Frequency: 40-50% of patients

Delayed or absent puberty

(constitutional)

Lack of development of secondary sexual characteristics by expected age.

Frequency: 60-70% of patients

Infertility

(reproductive)

Inability to conceive naturally due to gonadal dysfunction or anatomical abnormalities.

Frequency: 60-80% of patients

Short stature

(constitutional)

Height below expected genetic potential due to hormonal factors affecting growth.

Frequency: 15-20% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Multidisciplinary DSD team care

Coordinated care involving endocrinology, urology, gynecology, psychology, and genetics to provide comprehensive, patient-centered care.

monitoring
3

Psychosocial support and counseling

Individual and family counseling to address emotional adjustment, identity development, and social support needs.

psychological

Additional treatment options

Hormone replacement therapy

Testosterone or estrogen therapy as appropriate to support secondary sexual development and bone health based on assigned gender.

medication

Gonadal surgery if desired

Gonadectomy or genitoplasty procedures performed only with informed patient consent, addressing malignancy risk and personal preferences.

surgical

Peer support and community resources

Connection with support groups and patient advocacy organizations for shared experiences and practical guidance.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 46 Xy Differences Of Sex Development C2751824?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Lee PA, Houk CP, Ahmed SF, Hughes IA. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics. 2006;118(2):e488-e500.

guideline2006View source →
2

Endocrine Society. Management of congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2018;103(11):4043-4068.

guideline2018View source →
3

American Academy of Pediatrics. Policy statement: Evaluation and management of disorders of sex development. Pediatrics. 2008;121(2):e488-e500.

position_statement2008View source →
4

Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. Arch Dis Child. 2006;91(7):554-563.

consensus2006View source →
5

Mendonca BB, Domenice S, Arnhold IJ, Costa EM. Disorders of sex development: a review of the pathophysiology. Arq Bras Endocrinol Metab. 2009;53(6):691-700.

review2009View source →
6

Lee PA, Nordenström A, Houk CP, Ahmed SF, et al. Global disorders of sex development update since 2006: perceptions, approach and care. Horm Res Paediatr. 2016;85(3):158-180.

review2016View source →
7

Cohen-Kettenis PT, Pfäfflin F. The DSM diagnostic criteria for gender identity disorder in adolescents and adults. Arch Sex Behav. 2010;39(2):499-513.

position_statement2010View source →
8

Bouchard C, Chrousos GP. Update on congenital adrenal hyperplasia: from pathophysiology to clinical practice. Nat Rev Endocrinol. 2015;11(10):623-634.

clinical_trial2015View source →

Medication Comparisons

Compare medications used to treat 46 Xy Differences Of Sex Development C2751824. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy